Discontinuation report QUININE - ODAN
| Report ID | 187637 |
| Drug Identification Number | 00695440 |
| Brand name | QUININE - ODAN |
| Common or Proper name | Quinine Sulfate Capsules, USP |
| Company Name | ODAN LABORATORIES LTD |
| Market Status | DORMANT |
| Active Ingredient(s) | QUININE SULFATE |
| Strength(s) | 200MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | P01BC |
| ATC description | ANTIMALARIALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2022-08-31 |
| Remaining supply date | 2022-08-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | No inventory remaining |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2023-03-22 | French | Compare |
| v2 | 2023-03-22 | English | Compare |
| v1 | 2023-03-22 | English | Compare |
Showing 1 to 3 of 3